| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -2.77% | -125.2% | 67.56% | 124/140 | 1.2% | 惠泰医疗 | 15.7% | 行业排名> |
| 2025-12-31 | -8.54% | -13.41% | -132.7% | 118/140 | 2.37% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-09-30 | -3.67% | -195.97% | -21.52% | 122/140 | 4.19% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-06-30 | -3.02% | -29.06% | -145.53% | 122/140 | 2.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-03-31 | -1.23% | -920% | 83.67% | 120/140 | 1.42% | 惠泰医疗 | 15.03% | 行业排名> |
| 2024-12-31 | -7.53% | -316.02% | -507.26% | 117/140 | 4.14% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-09-30 | -1.24% | -176.54% | 47.01% | 113/140 | 5.03% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-06-30 | -2.34% | -250% | -1660% | 123/140 | 3.15% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-03-31 | 0.15% | -91.43% | 108.29% | 103/140 | 1.75% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2023-12-31 | -1.81% | -105.97% | -211.73% | 109/140 | 5.44% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-09-30 | 1.62% | -95.21% | 3.85% | 99/140 | 6.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-06-30 | 1.56% | -93.8% | -10.86% | 93/140 | 3.96% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-03-31 | 1.75% | -90.91% | -94.23% | 68/140 | 2.33% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2022-12-31 | 30.33% | -75.09% | -10.27% | 14/140 | 13.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-09-30 | 33.8% | -66.09% | 34.34% | 13/140 | 13.94% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | 25.16% | -74.61% | 30.63% | 13/140 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2022-03-31 | 19.26% | -66.58% | -84.18% | 12/140 | 6.8% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 121.78% | 672.23% | 22.16% | 1/140 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-09-30 | 99.69% | 12680.77% | 0.61% | 1/140 | 16.59% | 热景生物 | 121.78% | 行业排名> |
| 2021-06-30 | 99.09% | 34268.96% | 71.94% | 1/140 | 11.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-03-31 | 57.63% | 71937.5% | 265.44% | 1/140 | 6.49% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 15.77% | 91.38% | 1921.8% | 63/140 | 26.27% | 热景生物 | 57.63% | 行业排名> |
| 2020-09-30 | 0.78% | -87.23% | 368.97% | 83/140 | 19.98% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | -0.29% | -105.46% | -462.5% | 106/140 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-03-31 | 0.08% | 2% | -99.03% | 68/140 | 3.31% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 8.24% | -59.21% | 34.86% | 87/140 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-09-30 | 6.11% | 2% | 15.07% | 45/140 | 10.54% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 5.31% | 2% | -73.71% | 43/140 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 20.2% | 5.1% | 5.1% | 31/140 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 19.22% | -47.79% | -47.79% | 27/140 | 14.51% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 36.81% | 2% | 2% | 8/140 | 16.44% | 安旭生物 | 48.71% | 行业排名> |

微信公众号
证券之星APP


